Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | -$0.82 | -$0.81 | -$0.82 |
Q2 2024 | 1 | -$0.77 | -$0.76 | -$0.76 |
Q3 2024 | 1 | -$0.72 | -$0.71 | -$0.71 |
Q4 2024 | 2 | -$0.66 | -$0.59 | -$0.63 |
Q1 2025 | 2 | -$0.63 | -$0.58 | -$0.61 |
Q2 2025 | 1 | -$0.56 | -$0.55 | -$0.55 |
Q3 2025 | 1 | -$0.50 | -$0.49 | -$0.49 |
Q4 2025 | 1 | -$0.51 | -$0.50 | -$0.50 |
Q1 2026 | 1 | -$0.49 | -$0.48 | -$0.49 |
Q2 2026 | 1 | -$0.45 | -$0.44 | -$0.45 |
Q3 2026 | 1 | -$0.42 | -$0.41 | -$0.42 |
Twist Bioscience Corporation last posted its earnings results on Friday, August 2nd, 2024. The company reported $-0.86 earnings per share for the quarter, missing analysts' consensus estimates of $-0.79 by $0.07. The company had revenue of 84.71 M for the quarter and had revenue of 312.97 M for the year. Twist Bioscience Corporation has generated $-4 earnings per share over the last year ($-3.6 diluted earnings per share) and currently has a price-to-earnings ratio of -13.73. Twist Bioscience Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, January 31st, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/18/2024 | Q4 2024 | -$0.59 | $82.71 M | $84.71 M | ||
08/02/2024 | Q3 2024 | -$0.79 | -$1.47 | -0.68 | $77.40 M | $81.46 M |
05/02/2024 | Q2 2024 | -$0.84 | -$0.79 | 0.05 | $75.30 M | |
02/02/2024 | Q1 2024 | -$0.75 | $71.50 M | |||
11/21/2023 | Q4 2023 | -$0.81 | $63.35 M | $66.95 M | ||
08/07/2023 | Q3 2023 | -$1.01 | $60.62 M | $63.74 M | ||
05/08/2023 | Q2 2023 | -$1.04 | $60.18 M | |||
02/07/2023 | Q1 2023 | -$0.74 | $54.24 M | |||
06/05/2023 | Q4 2022 | -$0.91 | $56.90 M | $57.31 M | ||
08/08/2022 | Q3 2022 | -$1.08 | $52.06 M | $56.11 M | ||
05/06/2022 | Q2 2022 | -$1.13 | $48.13 M | |||
02/09/2022 | Q1 2022 | -$0.91 | $42.02 M | |||
11/22/2021 | Q4 2021 | -$0.84 | $36.60 M | $37.95 M | ||
08/09/2021 | Q3 2021 | -$0.82 | $32.42 M | $35.02 M | ||
05/07/2021 | Q2 2021 | -$0.78 | $31.20 M | |||
02/08/2021 | Q1 2021 | -$0.72 | $28.16 M | |||
11/25/2020 | Q4 2020 | -$0.55 | $22.95 M | $32.43 M | ||
08/12/2020 | Q3 2020 | -$0.67 | $14.18 M | $21.21 M | ||
05/12/2020 | Q2 2020 | -$0.85 | $19.30 M | |||
02/10/2020 | Q1 2020 | -$1.69 | $17.16 M |
Twist Bioscience Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, January 31st, 2025 based off last year's report dates.
The conference call for Twist Bioscience Corporation's latest earnings report can be listened to online.
The conference call transcript for Twist Bioscience Corporation's latest earnings report can be read online.
Twist Bioscience Corporation (:TWST) has a recorded annual revenue of $312.97 M.
Twist Bioscience Corporation (:TWST) has a recorded net income of $312.97 M. Twist Bioscience Corporation has generated $-3.6 earnings per share over the last four quarters.
Twist Bioscience Corporation (:TWST) has a price-to-earnings ratio of -13.73 and price/earnings-to-growth ratio is -2.38.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED